Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes
| العنوان: | Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes |
|---|---|
| المؤلفون: | Kumar Sharma, Mir Tariq Ali, David Z.I. Cherney, Daniel Montemayor, Hongyan Liu, Patrick R. Lawler, Leif E. Lovblom, Hongping Ye, Vikas S. Sridhar, Daniel Scarr, Yuliya Lytvyn, Bruce A. Perkins, Jiwan Kim |
| المصدر: | Diabetes, Obesity and Metabolism. 23:2466-2475 |
| بيانات النشر: | Wiley, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Metabolite, Urine, medicine.disease_cause, Young Adult, chemistry.chemical_compound, Endocrinology, Metabolomics, Glucosides, Internal medicine, Internal Medicine, Empagliflozin, Humans, Medicine, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Type 1 diabetes, business.industry, Hypoxia (medical), medicine.disease, Metabolic pathway, Diabetes Mellitus, Type 1, chemistry, Female, medicine.symptom, business, Oxidative stress |
| الوصف: | AIM To examine the impact of the sodium-glucose co-transporter-2 inhibitor, empagliflozin, on plasma and urine metabolites in participants with type 1 diabetes. MATERIAL AND METHODS Participants (n = 40, 50% male, mean age 24.3 years) with type 1 diabetes and without overt evidence of diabetic kidney disease had baseline assessments performed under clamped euglycaemia and hyperglycaemia, on two consecutive days. Participants then proceeded to an 8-week, open-label treatment period with empagliflozin 25 mg/day, followed by repeat assessments under clamped euglycaemia and hyperglycaemia. Plasma and urine metabolites were first grouped into metabolic pathways using MetaboAnalyst software. Principal component analysis was performed to create a representative value for each sufficiently represented metabolic group (false discovery rate ≤ 0.1) for further analysis. RESULTS Of the plasma metabolite groups, tricarboxylic acid (TCA) cycle (P |
| تدمد: | 1463-1326 1462-8902 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85379caa8dec557abd4fd02ab5d5993Test https://doi.org/10.1111/dom.14489Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....d85379caa8dec557abd4fd02ab5d5993 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14631326 14628902 |
|---|